v3.26.3
Organization (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
USD ($)
product
Jun. 30, 2026
USD ($)
Mar. 31, 2026
USD ($)
Sep. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2026
USD ($)
product
Sep. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]                  
Number of commercial-stage products | product 3           3    
Accumulated deficit $ 366,232           $ 366,232   $ 376,297
Net income 14,161 $ 2,206 $ (6,302) $ 5,074 $ (553) $ (11,246) 10,065 $ (6,725)  
Cash and cash equivalents 133,493           133,493   $ 100,092
Investments $ 102,100           $ 102,100